Novo Nordisk A/S
CSE:NOVO B
Balance Sheet
Balance Sheet Decomposition
Novo Nordisk A/S
Current Assets | 139.6B |
Cash & Short-Term Investments | 30.2B |
Receivables | 75.3B |
Other Current Assets | 34.2B |
Non-Current Assets | 174.8B |
Long-Term Investments | 1.7B |
PP&E | 91B |
Intangibles | 60.4B |
Other Non-Current Assets | 21.8B |
Current Liabilities | 169.7B |
Accounts Payable | 25.6B |
Other Current Liabilities | 144B |
Non-Current Liabilities | 38.3B |
Long-Term Debt | 20.5B |
Other Non-Current Liabilities | 17.7B |
Balance Sheet
Novo Nordisk A/S
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
14 396
|
16 923
|
18 690
|
18 852
|
15 638
|
14 966
|
12 104
|
9 597
|
12 195
|
13 535
|
|
Cash |
14 396
|
16 923
|
18 690
|
18 852
|
15 638
|
14 966
|
12 104
|
9 597
|
12 195
|
13 535
|
|
Short-Term Investments |
1 509
|
3 542
|
2 009
|
0
|
0
|
0
|
0
|
6 765
|
10 921
|
15 838
|
|
Total Receivables |
17 779
|
21 613
|
22 613
|
21 938
|
24 836
|
29 152
|
32 184
|
46 799
|
57 505
|
75 261
|
|
Accounts Receivables |
13 041
|
15 485
|
20 234
|
20 165
|
22 786
|
24 912
|
27 734
|
40 643
|
50 560
|
64 770
|
|
Other Receivables |
4 738
|
6 128
|
2 379
|
1 773
|
2 050
|
4 240
|
4 450
|
6 156
|
6 945
|
10 491
|
|
Inventory |
11 357
|
12 758
|
14 341
|
15 373
|
16 336
|
17 641
|
18 536
|
19 621
|
24 388
|
31 811
|
|
Other Current Assets |
1 252
|
304
|
2 113
|
3 917
|
2 257
|
697
|
2 985
|
2 813
|
3 185
|
3 201
|
|
Total Current Assets |
46 293
|
55 140
|
59 766
|
60 080
|
59 067
|
62 456
|
65 809
|
85 595
|
108 194
|
139 646
|
|
PP&E Net |
23 136
|
25 545
|
30 179
|
35 247
|
41 891
|
50 551
|
50 269
|
55 362
|
66 671
|
90 961
|
|
PP&E Gross |
23 136
|
25 545
|
30 179
|
35 247
|
41 891
|
50 551
|
50 269
|
55 362
|
66 671
|
90 961
|
|
Accumulated Depreciation |
24 348
|
25 625
|
27 845
|
29 414
|
30 547
|
33 869
|
36 417
|
40 525
|
44 755
|
47 622
|
|
Intangible Assets |
1 378
|
2 158
|
2 714
|
3 325
|
5 145
|
5 835
|
20 657
|
38 825
|
46 324
|
55 942
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 346
|
5 092
|
4 464
|
|
Note Receivable |
0
|
0
|
689
|
567
|
477
|
1 205
|
974
|
630
|
663
|
2 112
|
|
Long-Term Investments |
856
|
2 150
|
1 508
|
1 195
|
1 296
|
1 444
|
1 348
|
1 078
|
886
|
981
|
|
Other Long-Term Assets |
5 399
|
6 806
|
2 683
|
1 941
|
2 893
|
4 121
|
5 865
|
8 672
|
13 427
|
20 380
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 346
|
5 092
|
4 464
|
|
Total Assets |
77 062
N/A
|
91 799
+19%
|
97 539
+6%
|
102 355
+5%
|
110 769
+8%
|
125 612
+13%
|
144 922
+15%
|
194 508
+34%
|
241 257
+24%
|
314 486
+30%
|
|
Liabilities | |||||||||||
Accounts Payable |
4 950
|
4 927
|
6 011
|
5 610
|
6 756
|
6 358
|
5 717
|
8 870
|
15 587
|
25 606
|
|
Accrued Liabilities |
9 794
|
11 281
|
11 051
|
6 799
|
7 015
|
478
|
598
|
590
|
875
|
600
|
|
Short-Term Debt |
720
|
1 073
|
229
|
1 694
|
515
|
659
|
6 684
|
12 862
|
480
|
456
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
815
|
775
|
822
|
986
|
6 022
|
|
Other Current Liabilities |
18 225
|
23 592
|
30 145
|
32 953
|
39 878
|
50 673
|
56 499
|
76 372
|
103 012
|
136 971
|
|
Total Current Liabilities |
33 689
|
40 873
|
47 436
|
47 056
|
54 164
|
58 983
|
70 273
|
99 516
|
120 940
|
169 655
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
3 009
|
2 897
|
12 961
|
24 318
|
20 528
|
|
Deferred Income Tax |
7
|
6
|
13
|
846
|
118
|
80
|
2 502
|
5 271
|
4 685
|
6 376
|
|
Other Liabilities |
3 072
|
3 951
|
4 821
|
4 638
|
4 648
|
5 947
|
5 925
|
6 014
|
7 828
|
11 366
|
|
Total Liabilities |
36 768
N/A
|
44 830
+22%
|
52 270
+17%
|
52 540
+1%
|
58 930
+12%
|
68 019
+15%
|
81 597
+20%
|
123 762
+52%
|
157 771
+27%
|
207 925
+32%
|
|
Equity | |||||||||||
Common Stock |
530
|
520
|
510
|
500
|
490
|
480
|
470
|
462
|
456
|
451
|
|
Retained Earnings |
42 244
|
48 062
|
47 607
|
48 855
|
54 102
|
58 291
|
63 589
|
72 934
|
80 625
|
104 522
|
|
Treasury Stock |
11
|
10
|
9
|
11
|
11
|
10
|
8
|
6
|
6
|
5
|
|
Other Equity |
2 469
|
1 603
|
2 839
|
471
|
2 742
|
1 168
|
726
|
2 644
|
2 411
|
1 593
|
|
Total Equity |
40 294
N/A
|
46 969
+17%
|
45 269
-4%
|
49 815
+10%
|
51 839
+4%
|
57 593
+11%
|
63 325
+10%
|
70 746
+12%
|
83 486
+18%
|
106 561
+28%
|
|
Total Liabilities & Equity |
77 062
N/A
|
91 799
+19%
|
97 539
+6%
|
102 355
+5%
|
110 769
+8%
|
125 612
+13%
|
144 922
+15%
|
194 508
+34%
|
241 257
+24%
|
314 486
+30%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
4 649
|
4 658
|
4 471
|
4 351
|
4 251
|
4 167
|
4 088
|
4 015
|
3 963
|
4 458
|